High levels of IgM against methylglyoxal-modified apolipoprotein B 100 is associated with less coronary artery calcification in patients with type 2 diabetes.

DSpace Repository

High levels of IgM against methylglyoxal-modified apolipoprotein B 100 is associated with less coronary artery calcification in patients with type 2 diabetes.

Show full item record

Files for download

Find Full text There are no files associated with this item..

Facebook

Simple item record

Publication Article, peer reviewed scientific
Title High levels of IgM against methylglyoxal-modified apolipoprotein B 100 is associated with less coronary artery calcification in patients with type 2 diabetes.
Author(s) Engelbertsen, Daniel ; Anand, DV ; Nordin Fredrikson, Gunilla ; Hopkins, D ; Corder, R ; Shah, Prediman K ; Lahiri, A ; Nilsson, Jan ; Bengtsson, Eva
Date 2011
DOI http://dx.doi.org/10.1111/j.1365-2796.2011.02411.x (link to publisher's fulltext.)
Link http://www.ncbi.nlm.nih.gov/pubmed/21668821 (external link to publication)
Host/Issue J Intern Med;
Volume In press
Language eng (iso)
Subject(s) Medicine
Research Subject Categories::MEDICINE
Handle http://hdl.handle.net/2043/12826 (link to this page)

This item appears in the following Collection(s)

Show full item record

Search


Browse

My Account

Statistics